Abbisko Therapeutics
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A clinical-stage oncology company developing novel small molecule therapies targeting key cancer pathways.
Oncology
Technology Platform
A proprietary discovery platform focused on structure-based drug design and translational medicine for oncology targets.
Opportunities
Large and growing oncology market in China, with potential for out-licensing candidates globally.
Risk Factors
Clinical failure of lead candidates and high burn rate in a competitive sector.
Competitive Landscape
Faces intense competition in targeted oncology from large global pharma and numerous Chinese biotechs developing similar pathway inhibitors.